Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis

IMPORTANCE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors favorably affect cardiovascular (CV) and kidney outcomes; however, the consistency of outcomes across the class remains uncertain. OBJECTIVE: To perform meta-analyses that assess the CV and kidney outcomes of all 4 available SGLT2 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Darren K., Shih, Weichung J., Cosentino, Francesco, Charbonnel, Bernard, Cherney, David Z. I., Dagogo-Jack, Samuel, Pratley, Richard, Greenberg, Michelle, Wang, Shuai, Huyck, Susan, Gantz, Ira, Terra, Steven G., Masiukiewicz, Urszula, Cannon, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542529/
https://www.ncbi.nlm.nih.gov/pubmed/33031522
http://dx.doi.org/10.1001/jamacardio.2020.4511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542529/
https://www.ncbi.nlm.nih.gov/pubmed/33031522
http://dx.doi.org/10.1001/jamacardio.2020.4511

Ejemplares similares